Optimal treatment strategy and prognostic analysis for patients with non-metastatic pT4 colon adenocarcinoma.

Front Oncol · 2023 · PMC10802841 · PMID 38260849

Europe PMC DOI

hedged sentence

0.6550

closest p · 13.1× alpha

0.6550

boldest claim

The sentences

did not reach statistical significanceP = 0.655not close (p > 0.1)

1.555, P < 0.05), while the risk in grade II, though higher than grade I, did not reach statistical significance (P = 0.655).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.